Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
Expert Opinion on Investigational Drugs|April 7, 2011
Novel C-C chemokine receptor 2 antagonists in metabolic disease: a review of recent developmentsYoung Sun Kang, Jin Joo Cha, Young Youl Hyun, et al.Kidney Research and Clinical Practice|October 14, 2022
Adenosine receptors as emerging therapeutic targets for diabetic kidney diseaseEun Seon Pak, Jin Joo Cha, Dae Ryong Cha, et al.Life (Basel, Switzerland)|May 27, 2026
VSIG4 Expression During Renal Aging Is Accelerated by Type 2 Diabetes in MiceSang Youb Han, Jungyeon Ghee, Jin Joo Cha, et al.Kidney & Blood Pressure Research|January 7, 2024
Dapagliflozin Does Not Protect against Adriamycin-Induced Kidney Injury in MiceJin Joo Cha, Hye-Jin Park, Ji Ae Yoo, et al.Animal Cells and Systems|April 24, 2023
Puromycin-induced kidney injury and subsequent regeneration in adult zebrafishSoonil Koun, Hye-Jin Park, Su-Min Jung, et al.Life (Basel, Switzerland)|April 28, 2023
SH3YL1 Protein Predicts Renal Outcomes in Patients with Type 2 DiabetesSang Youb Han, Seung Hyun Han, Jung Yeon Ghee, et al.Acta Diabetologica|January 5, 2021
Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal modelSang Youb Han, Hye Kyoung Song, Jin Joo Cha, et al.Life (Basel, Switzerland)|July 27, 2022
Upregulation of VSIG4 in Type 2 Diabetic Kidney DiseaseSang Youb Han, Jung Yeon Ghee, Jin Joo Cha, et al.Life (Basel, Switzerland)|February 25, 2023
The Role of V-Set Ig Domain-Containing 4 in Chronic Kidney Disease ModelsSang Youb Han, Jung Yeon Ghee, Jin Joo Cha, et al.Chonnam Medical Journal|September 7, 2013
Pseudomyxoma peritonei: a rare cause of oliguric acute kidney injuryHye Sook Min, Jeung Hui Pyo, Eul Sun Moon, et al.Pageof 4